Journal
UROLOGIC CLINICS OF NORTH AMERICA
Volume 49, Issue 2, Pages 309-321Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ucl.2022.01.001
Keywords
Androgen antagonists; Androgen deprivation therapy; Hormonal adverse effects; Hormone treatment; Prostatic neoplasm